Detalhe da pesquisa
1.
Detecting Förster resonance energy transfer in living cells by conventional and spectral flow cytometry.
Cytometry A
; 101(10): 818-834, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128311
2.
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.
Br J Haematol
; 189(4): 650-660, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32180219
3.
Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
Blood
; 122(3): 357-66, 2013 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23741006
4.
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.
Am J Hematol
; 94(6): E150-E153, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30785215
5.
Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.
J Immunother Cancer
; 11(11)2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007239
6.
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights.
Leuk Res
; 121: 106928, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963025
7.
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.
Blood Adv
; 6(4): 1143-1151, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015819
8.
miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGFßR3.
J Invest Dermatol
; 142(7): 1956-1965.e2, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890627
9.
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther
; 7(1): 51, 2022 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35185150
10.
Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individuals.
Exp Dermatol
; 25(3): 245-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475987
11.
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K ß/δ in relapsed refractory B cell lymphoma.
Leuk Lymphoma
; 62(14): 3452-3462, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34365878
12.
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity.
Leukemia
; 33(11): 2640-2653, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028278
13.
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.
Clin Cancer Res
; 24(14): 3366-3376, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496759
14.
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther
; 7(1): 110, 2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365596
15.
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
Oncotarget
; 7(48): 79722-79735, 2016 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27806325
16.
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling.
Cancer Cell
; 29(5): 639-652, 2016 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27132469
17.
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
PLoS One
; 10(9): e0137210, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26340096
18.
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Int J Radiat Oncol Biol Phys
; 92(1): 113-21, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25863759